Identification and simultaneous quantification of potential genotoxic impurities in first-line HIV drug dolutegravir sodium using fast ultrasonication-assisted extraction method coupled with GC–MS and in-silico toxicity assessment

IF 2.8 3区 医学 Q2 BIOCHEMICAL RESEARCH METHODS
Elumalai Sambandan , Kathavarayan Thenmozhi , G. Santosh , Chun-Chi Wang , Pei-Chien Tsai , Swapnil Gurrani , Sellappan Senthilkumar , Yi-Hsun Chen , Vinoth Kumar Ponnusamy
{"title":"Identification and simultaneous quantification of potential genotoxic impurities in first-line HIV drug dolutegravir sodium using fast ultrasonication-assisted extraction method coupled with GC–MS and in-silico toxicity assessment","authors":"Elumalai Sambandan ,&nbsp;Kathavarayan Thenmozhi ,&nbsp;G. Santosh ,&nbsp;Chun-Chi Wang ,&nbsp;Pei-Chien Tsai ,&nbsp;Swapnil Gurrani ,&nbsp;Sellappan Senthilkumar ,&nbsp;Yi-Hsun Chen ,&nbsp;Vinoth Kumar Ponnusamy","doi":"10.1016/j.jchromb.2024.124275","DOIUrl":null,"url":null,"abstract":"<div><p>Dolutegravir (DLG) has become a distinctive first-line antiretroviral therapy for the treatment of HIV in most countries due to its affordability, high efficacy, and low drug-drug interactions. However, the evaluation of genotoxic impurities (GTIs) in DLG and their toxicity assessment has not been explored thoroughly. Thus, in this study, a simple, fast, and selective analytical methodology was developed for the identification and determination of 7 GTIs in the comprehensive, explicit route of synthesis for the dolutegravir sodium (DLG-Na) drug. A facile, fast ultrasonication-assisted liquid–liquid extraction procedure was adapted to isolate the GTIs in DLG-Na and then analyzed using the gas chromatography (GC)-electron impact (EI)/mass spectrometer (MS) quantification (using selective ion monitoring mode) technique. This EI-GC/MS method was validated as per the current requirements of ICH Q2 (R1) guidelines. Under optimal method conditions, excellent linearities were achieved with R between 0.9959 and 0.9995, and high sensitivity was obtained in terms of detection limits (LOD) between 0.15 to 0.63 µg/g, and quantification limits (LOQ) between 0.45 to 1.66 µg/g for the seven GTIs in DLG. The obtained recoveries ranged from 98.2 to 104.3 % at LOQ, 15 µg/g, and 18 µg/g concentration levels (maximum daily dose of 100 mg). This developed and validated method is rapid, easy to adopt, specific, sensitive, and accurate in estimating the seven GTIs in a relatively complex sodium matrix of the DLG-Na drug moiety. As a method application, two different manufactured samples of DLG-Na drug substances were analyzed for the fate of the GTIs and drug safety for the intended dosage applications. Moreover, an <em>in-silico</em> QSAR toxicity prediction assessment was carried out to prove scientifically the potential GTI nature of each impurity from the alerting functional groups.</p></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1245 ","pages":"Article 124275"},"PeriodicalIF":2.8000,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Chromatography B","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1570023224002848","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Dolutegravir (DLG) has become a distinctive first-line antiretroviral therapy for the treatment of HIV in most countries due to its affordability, high efficacy, and low drug-drug interactions. However, the evaluation of genotoxic impurities (GTIs) in DLG and their toxicity assessment has not been explored thoroughly. Thus, in this study, a simple, fast, and selective analytical methodology was developed for the identification and determination of 7 GTIs in the comprehensive, explicit route of synthesis for the dolutegravir sodium (DLG-Na) drug. A facile, fast ultrasonication-assisted liquid–liquid extraction procedure was adapted to isolate the GTIs in DLG-Na and then analyzed using the gas chromatography (GC)-electron impact (EI)/mass spectrometer (MS) quantification (using selective ion monitoring mode) technique. This EI-GC/MS method was validated as per the current requirements of ICH Q2 (R1) guidelines. Under optimal method conditions, excellent linearities were achieved with R between 0.9959 and 0.9995, and high sensitivity was obtained in terms of detection limits (LOD) between 0.15 to 0.63 µg/g, and quantification limits (LOQ) between 0.45 to 1.66 µg/g for the seven GTIs in DLG. The obtained recoveries ranged from 98.2 to 104.3 % at LOQ, 15 µg/g, and 18 µg/g concentration levels (maximum daily dose of 100 mg). This developed and validated method is rapid, easy to adopt, specific, sensitive, and accurate in estimating the seven GTIs in a relatively complex sodium matrix of the DLG-Na drug moiety. As a method application, two different manufactured samples of DLG-Na drug substances were analyzed for the fate of the GTIs and drug safety for the intended dosage applications. Moreover, an in-silico QSAR toxicity prediction assessment was carried out to prove scientifically the potential GTI nature of each impurity from the alerting functional groups.

Abstract Image

利用快速超声辅助萃取法结合气相色谱-质谱联用仪和体内毒性评估,鉴定并同时定量分析一线艾滋病毒药物多鲁特韦钠中潜在的基因毒性杂质
多罗替拉韦(Dolutgravir,DLG)因其价格低廉、疗效显著、药物间相互作用小等特点,已成为大多数国家治疗艾滋病的一线抗逆转录病毒疗法。然而,对 DLG 中的基因毒性杂质(GTIs)及其毒性评估的研究还不够深入。因此,本研究开发了一种简单、快速、选择性强的分析方法,用于鉴定和测定多鲁曲韦钠(DLG-Na)药物综合明确合成路线中的 7 种 GTIs。该方法采用简便、快速的超声辅助液液萃取程序分离出 DLG-Na 中的 GTIs,然后使用气相色谱(GC)-电子碰撞(EI)/质谱仪(MS)定量(使用选择性离子监测模式)技术进行分析。该 EI-GC/MS 方法按照现行的 ICH Q2 (R1) 指南要求进行了验证。在最佳方法条件下,该方法的线性关系良好,R值介于0.9959和0.9995之间;灵敏度高,对DLG中的7种GTI的检出限(LOD)介于0.15至0.63 µg/g之间,定量限(LOQ)介于0.45至1.66 µg/g之间。在LOQ、15微克/克和18微克/克浓度水平(最大日剂量为100毫克)下,回收率为98.2%至104.3%。该方法快速、简便、特异、灵敏、准确,可在相对复杂的DLG-Na药物钠基质中准确测定7种GTI。应用该方法对两种不同的DLG-Na药物样品进行了分析,以确定GTIs的去向和药物在预期剂量应用中的安全性。此外,该方法还进行了室内 QSAR 毒性预测评估,以科学地证明每种杂质的警戒官能团可能具有 GTI 性质。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Chromatography B
Journal of Chromatography B 医学-分析化学
CiteScore
5.60
自引率
3.30%
发文量
306
审稿时长
44 days
期刊介绍: The Journal of Chromatography B publishes papers on developments in separation science relevant to biology and biomedical research including both fundamental advances and applications. Analytical techniques which may be considered include the various facets of chromatography, electrophoresis and related methods, affinity and immunoaffinity-based methodologies, hyphenated and other multi-dimensional techniques, and microanalytical approaches. The journal also considers articles reporting developments in sample preparation, detection techniques including mass spectrometry, and data handling and analysis. Developments related to preparative separations for the isolation and purification of components of biological systems may be published, including chromatographic and electrophoretic methods, affinity separations, field flow fractionation and other preparative approaches. Applications to the analysis of biological systems and samples will be considered when the analytical science contains a significant element of novelty, e.g. a new approach to the separation of a compound, novel combination of analytical techniques, or significantly improved analytical performance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信